메뉴 건너뛰기




Volumn 37, Issue 7, 2012, Pages 399-404

Hydrocodone rescheduling amendment and pipeline products on the horizon

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCODONE; HYDROCODONE BITARTRATE; UNCLASSIFIED DRUG; ZOHYDRO;

EID: 84865956066     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (10)

References (16)
  • 1
    • 84865957611 scopus 로고    scopus 로고
    • Drug Enforcement Administration, June 2011, Available at, Accessed June 11
    • Drug Enforcement Administration. Hydrocodone, June 2011. Available at: www.deadiversion.usdoj.gov/drugs_concern/hydrocodone.pdf. Accessed June 11, 2012.
    • (2012) Hydrocodone
  • 2
    • 84856334928 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, Summary and National Findings, September 2011. Available at, Accessed June 11
    • U.S. Department of Health and Human Services. Results from the 2010 National Survey on Drug Use and Health: Summary and National Findings, September 2011. Available at: www.samhsa.gov/data/NSDUH/2k10NSDUH/2k10Results.htm#TabC-1. Accessed June 11, 2012.
    • (2012) Results From the 2010 National Survey On Drug Use and Health
  • 3
    • 84860589351 scopus 로고    scopus 로고
    • Substance Abuse and Mental Health Services Administration, Vicodin: Trends in Annual Use Grades 8, 10, and 12, December 2011. Available at:
    • Substance Abuse and Mental Health Services Administration. The Monitoring the Future Study. Vicodin: Trends in Annual Use Grades 8, 10, and 12, December 2011. Available at: www.monitoringthefuture.org/data/11data/fig11_8.pdf. Accessed June 11, 2012.
    • (2012) The Monitoring the Future Study
  • 4
    • 84865983020 scopus 로고    scopus 로고
    • Code of Federal Regulations. Title 21, June 2012, Available at, Accessed June 11
    • Code of Federal Regulations. Title 21: Food and Drugs Part 1308 Schedules of Controlled Substances 1308.12 Schedule II, June 2012. Available at: http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=8a13fb1f4c0 d7fdcb908504abaec4670&rgn=div8&view=text&node=21:9.0.1.1.9.0 .26.5&idno=21. Accessed June 11, 2012.
    • Food and Drugs Part 1308 Schedules of Controlled Substances 1308.12 Schedule II
  • 5
    • 84865983311 scopus 로고    scopus 로고
    • Code of Federal Regulations, June 2012, Available at, Accessed June 11
    • Code of Federal Regulations. Title 21: Food and Drugs Part 1308 Schedules of Controlled Substances 1308.13 Schedule III, June 2012. Available at: http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=8a13fb1f4c0 d7fdcb908504abaec4670&rgn=div8&view=text&node=21:9.0.1.1.9.0 .26.6&idno=21. Accessed June 11, 2012.
    • (2012) Title 21: Food and Drugs Part 1308 Schedules of Controlled Substances 1308.13 Schedule III
  • 6
    • 84865960287 scopus 로고    scopus 로고
    • U.S. Government Printing Office (GPO, May 24, 2012, Available at, Accessed June 11
    • U.S. Government Printing Office (GPO). Federal Digital System. 112th Congress 2D Session S. 3187, May 24, 2012. Available at: www.gpo.gov:80/fdsys/pkg/BILLS-112s3187es/pdf/BILLS-112s3187es.pdf. Accessed June 11, 2012.
    • (2012) Federal Digital System. 112th Congress 2D Session S. 3187
  • 7
    • 84865960288 scopus 로고    scopus 로고
    • National Association of Boards of Pharmacy, Senate, May 2012, Available at, Accessed June 11
    • National Association of Boards of Pharmacy. Amendment to reclassify hydrocodone as schedule ii controlled substance passes U.S. Senate, May 2012. Available at: www.nabp.net/news/amendmentto-reclassify-hydrocodone-as-schedule-ii-cont rolled-substancepasses-us-senate/. Accessed June 11, 2012.
    • (2012) Amendment to Reclassify Hydrocodone As Schedule Ii Controlled Substance Passes U.S
  • 8
    • 84865957614 scopus 로고    scopus 로고
    • American Pharmacists Association, May 2012. Available at, Accessed June 11
    • American Pharmacists Association. Senate passes Hydrocodone Rescheduling Amendment, May 2012. Available at: www.pharmacist.com/AM/Template.cfm?Section=Pharmacy_News&Template=/C M/ContentDisplay.cfm&ContentID=28562. Accessed June 11, 2012.
    • (2012) Senate Passes Hydrocodone Rescheduling Amendment
  • 10
    • 84865987957 scopus 로고    scopus 로고
    • Code of Federal Regulations, Requirement of Prescription, June 2012. Available at, Accessed June 11
    • Code of Federal Regulations. Title 21: Food and Drugs Controlled Substances Listed in Schedule II.1306.11 Requirement of Prescription, June 2012. Available at: http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=8a13fb1f4c0 d7fdcb908504abaec4670&rgn=div5&view=text&node=21:9.0.1.1.7&idno=21#21:9.0.1.1.7.0.19.10. Accessed June 11, 2012.
    • (2012) Title 21: Food and Drugs Controlled Substances Listed In Schedule II.1306.11
  • 11
    • 84865973804 scopus 로고    scopus 로고
    • American Pharmacists Association, May 2012, Available at, Accessed June 11
    • American Pharmacists Association. Opposition to rescheduling hydrocodone combination products, May 2012. Available at: www.ncpanet.org/pdf/leg/may12/hydrocodone_s.pdf. Accessed June 11, 2012.
    • (2012) Opposition to Rescheduling Hydrocodone Combination Products
  • 12
    • 84865998315 scopus 로고    scopus 로고
    • Zohydro (hydrocodone bitartrate) extended release capsules, Available at:, Accessed June 11
    • Zohydro (hydrocodone bitartrate) extended release capsules. San Diego: Zogenix. Available at: www.zogenix.com/index.php/products/zx002/. Accessed June 11, 2012.
    • (2012) San Diego: Zogenix
  • 15
    • 84865956971 scopus 로고    scopus 로고
    • Abuse experts worried. Available at, Accessed June 12
    • Teva Pharmaceuticals plans to market hydrocodone; Abuse experts worried. Available at: www.huffingtonpost.com/2012/01/13/hydrocodone-addictive-painkiller-teva_ n_1204470.html. Accessed June 12, 2012.
    • (2012) Teva Pharmaceuticals Plans to Market Hydrocodone
  • 16
    • 77956707359 scopus 로고    scopus 로고
    • Abuse-deterrent and tamper-resistant opioid formulations what is their role in addressing prescription opioid abuse?
    • Schneider JP, Matthews M, Jamison RN. Abuse-deterrent and tamper-resistant opioid formulations what is their role in addressing prescription opioid abuse? CNS Drugs 2010;24(10):805-810.
    • (2010) CNS Drugs , vol.24 , Issue.10 , pp. 805-810
    • Schneider, J.P.1    Matthews, M.2    Jamison, R.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.